LEVAMISOLE BEHANDELING BIJ REUMATOIDE ARTRITIS = TRAITEMENT PAR LEVAMISOLE DANS LA POLYARTHRITE RHUMATOIDEVEYS EM; MIELANTS H.1979; ACTA RHUMATOL.; BEL; DA. 1979; VOL. 3; NO 3; PP. 219-230; ABS. ENG; BIBL. 12 REF.Article

A GENETIC ACRO-OSTEOLYSIS SYNDROME: A HAJDU-CHENEY SYNDROMECOIGNE E; VEYS E; RAEMAN F et al.1978; ACTA RHUMATOL. BELG.; BEL; DA. 1978; VOL. 2; NO 1-2; PP. 45-51; BIBL. 16 REF.Article

HLA AND JUVENILE CHRONIC POLYARTHRITIS.VEYS EM; COIGNE E; MIELANTS H et al.1976; TISSUE ANTIGENS; DENM.; DA. 1976; VOL. 8; NO 1; PP. 61-65; BIBL. 12 REF.Article

HLA-B27 related arthritis and bowel inflammation. I: Sulfasalazine (salazopyrin) in HLA-B27 related reactive arthritisMIELANTS, H; VEYS, E. M.Journal of rheumatology. 1985, Vol 12, Num 2, pp 287-293, issn 0315-162XArticle

COMPARISON OF SERUM SALICYLATE LEVELS AND GASTRO-INTESTINAL BLOOD LOSS BETWEEN SALSALATE (DISALCID) AND OTHER FORMS OF SALICYLATESMIELANTS H; VEYS EM; VERBRUGGEN G et al.1981; SCAND. J. RHEUMATOL.; ISSN 0300-9742; SWE; DA. 1981; VOL. 10; NO 3; PP. 169-173; BIBL. 10 REF.Article

Les manifestations articulaires des entéropathies = Joint manifestations associated with intestinal diseasesMIELANTS, H; VEYS, E. M.Revue du rhumatisme (Ed. française). 1993, Vol 60, Num 11, pp 775-779, issn 1169-8330Article

Clinical trials on the efficacy and toxicity of slow acting anterheumatic drugs Essais cliniques sur l'efficacité et la toxicité des traitements de fond en rhumatologieVEYS, E.M; MIELANTS, H.Revue d'épidémiologie et de santé publique. 1984, Vol 32, Num 3-4, pp 230-236, issn 0398-7620Article

RHEUMATOID FACTOR AND SERUM IGG, IGM AND IGA LEVELS IN RHEUMATOID ARTHRITIS WITH VASCULITIS.VEYS EM; GABRIEL PA; COIGNE E et al.1976; SCAND. J. RHEUMATOL.; SWED.; DA. 1976; VOL. 5; NO 1; PP. 1-6; BIBL. 16 REF.Article

LEVAMISOLE AS BASIC TREATMENT OF RHEUMATOID ARTHRITIS: LONGTERM EVALUATIONVEYS EM; MIELANTS H; VERBRUGGEN G et al.1981; J. RHEUMATOL.; ISSN 0315-162X; CAN; DA. 1981; VOL. 8; NO 1; PP. 45-56; BIBL. 9 REF.Article

INTRICATIONS OF CONNECTIVE TISSUE DISEASESMIELANTS H; VEYS EM; VERBRUGGEN G et al.1978; ACTA RHUMATOL. BELG.; BEL; DA. 1978; VOL. 2; NO 3-4; PP. 141-162; BIBL. 24 REF.Article

ETUDE DES PERTES DE SANG OCCULTES PAR LA METHODE AU CHROME RADIOACTIF AU COURS D'UN TRAITEMENT A L'ACIDE ACETYLSALICYLIQUE. INFLUENCE DE L'ENROBAGE D'ACETOPHTALATE DE CELLULOSEVEYS EM; SIRON G; COIGNE E et al.1975; PHARM. ACTA HELV.; SUISSE; DA. 1975; VOL. 50; NO 5; PP. 156-158Article

DE NIET-CHIRURGISCHE BEHANDELING VAN DE BACTERIELE SEPTISCHE ARTHRITIS. = LE TRAITEMENT NON CHIRURGICAL DE L'ARTHRITE SEPTIQUE BACTERIENNEMIELANTS H; VEYS EM; RAEMAN F et al.1976; J. BELGE RHUMATOL. MED. PHYS.; BELG.; DA. 1976; VOL. 31; NO 4; PP. 187-197; BIBL. 8 REF.Article

Nouvelles perspectives de l'immunothérapie dans la polyarthrite rhumatoïde = New insights into immunotherapy of rheumatoid arthitisVEYS, E. M; MIELANTS, H; VERBRUGGEN, G et al.Annales de médecine interne (Paris). 1990, Vol 141, Num 4, pp 349-366, issn 0003-410XArticle

Involvement of the zygapophyseal joint in ankylosing spondylitis : Relation to the bridging syndesmophyteDE VLAM, K; MIELANTS, H; VEYS, E. M et al.Journal of rheumatology. 1999, Vol 26, Num 8, pp 1738-1745, issn 0315-162XArticle

The zygapophyseal joint determines morphology of the enthesophyteDE VLAM, K; MIELANTS, H; VERSTRAETE, K. L et al.Journal of rheumatology. 2000, Vol 27, Num 7, pp 1732-1739, issn 0315-162XArticle

Cervical septic spondylodiscitis in association with diffuse idiopathic skeletal hyperostosisSTUER, A; DE VLAM, K; VEYS, E. M et al.Journal of rheumatology. 1999, Vol 26, Num 12, pp 2710-2711, issn 0315-162XArticle

Simultaneous occurrence of diffuse idiopathic skeletal hyperostosis and ankylosing spondylitis in the same patientMAERTENS, M; MIELANTS, H; VERSTRATETE, K et al.Journal of rheumatology. 1992, Vol 19, Num 12, pp 1978-1983, issn 0315-162XArticle

Major histocompatibility complex class II antigen (HLA-DR) expression by ileal epithelial cells in patients with seronegative spondylarthropathyCUVELIER, C; MIELANTS, H; DE VOS, M et al.Gut. 1990, Vol 31, Num 5, pp 545-549, issn 0017-5749Article

Hajdu-cheney syndromeVERVAET, V; VERSTRAETE, K; VANNEUVILLE, B et al.Journal belge de radiologie (1907). 2001, Vol 84, Num 2, issn 0021-7646, p. 80Article

Intervention with immunomodulatory agents: new pharmaceutical developmentsVEYS, E. M; MIELANTS, H; VERBRUGGEN, G et al.Baillière's clinical rheumatology. 1992, Vol 6, Num 2, pp 455-484, issn 0950-3579Article

A RED FACE IN A LUPUS PATIENT: THINKING BEYOND LUPUS RASHSTUBBE, M; SMITH, V; THEVISSEN, K et al.Acta clinica belgica (Ed. multilingue). 2010, Vol 65, Num 1, pp 44-47, issn 0001-5512, 4 p.Article

Bone and joint diseases in inflammatory bowel diseaseDE VOS, M; DE KEYSER, F; MIELANTS, H et al.Alimentary pharmacology & therapeutics. 1998, Vol 12, Num 5, pp 397-404, issn 0269-2813Article

Long-term evolution of gut inflammation in patients with spondyloarthropathyDE VOS, M; MIELANTS, H; CUVELIER, C et al.Gastroenterology (New York, NY. 1943). 1996, Vol 110, Num 6, pp 1696-1703, issn 0016-5085Article

Immunoglobulin containing cells in terminal ileum and colorectum of patients with arthritis related gut inflammationCUVELIER, C; MIELANTS, H; DE VOS, M et al.Gut. 1988, Vol 29, Num 7, pp 916-925, issn 0017-5749Article

The role of gut inflammation in the pathogenesis of spondyloarthropathiesMIELANTS, H; DE VOS, M; CUVELIER, C et al.Acta Clinica Belgica. 1996, Vol 51, Num 5, pp 340-349, issn 0001-5512Article